NUASPIRIN Trademark
Trademark Overview
On Monday, April 8, 1996, a trademark application was filed for NUASPIRIN with the United States Patent and Trademark Office. The USPTO has given the NUASPIRIN trademark a serial number of 75085975. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, June 4, 1997. This trademark is owned by HEALTH CORPORATION. The NUASPIRIN trademark is filed in the Pharmaceutical Products category with the following description:
pain reliever medication
General Information
Serial Number | 75085975 |
Word Mark | NUASPIRIN |
Filing Date | Monday, April 8, 1996 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, June 4, 1997 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | pain reliever medication |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 8 - Abandoned |
Class Status Date | Wednesday, August 4, 1999 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | HEALTH CORPORATION |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Rocky Mount, NC 27804 |
Trademark Events
Event Date | Event Description |
Wednesday, June 4, 1997 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, September 20, 1996 | NON-FINAL ACTION MAILED |
Monday, September 16, 1996 | ASSIGNED TO EXAMINER |
Tuesday, September 10, 1996 | ASSIGNED TO EXAMINER |